Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346–66.

Article  PubMed  PubMed Central  Google Scholar 

Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540–55.

Article  CAS  PubMed  Google Scholar 

Vajaria BN, Patel PS. Glycosylation: a hallmark of cancer? Glycoconj J. 2017;34:147–56.

Article  CAS  PubMed  Google Scholar 

Mereiter S, Balmana M, Campos D, Gomes J, Reis CA. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell. 2019;36:6–16.

Article  CAS  PubMed  Google Scholar 

In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M et al. editors. Essentials of Glycobiology, 4th edn. New York: Cold Spring Harbor; 2022.

Comunale MA, Lowman M, Long RE, Krakover J, Philip R, Seeholzer S, et al. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res. 2006;5:308–15.

Article  CAS  PubMed  Google Scholar 

Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, et al. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res. 2009;15:1808–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta A, Norton P, Liang H, Comunale MA, Wang M, Rodemich-Betesh L, et al. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue. Cancer Epidemiol Biomark Prev. 2012;21:925–33.

Article  CAS  Google Scholar 

Mehta A, Herrera H, Block T. Glycosylation and liver cancer. Adv Cancer Res. 2015;126:257–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M et al. editors. Essentials of Glycobiology, 3rd edn. New York: Cold Spring Harbor; 2015.

Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22:736–56.

Article  CAS  PubMed  Google Scholar 

Brockhausen I, Stanley P O-GalNAc Glycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M et al. editors. Essentials of Glycobiology, 3rd edn. New York: Cold Spring Harbor; 2015, pp 113–23.

Zachara N, Akimoto Y, Hart GW The O-GlcNAc Modification. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M et al. editors. Essentials of Glycobiology, 3rd edn. New York: Cold Spring Harbor; 2015, pp 239–51.

Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci. 2010;123:13–22.

Article  CAS  PubMed  Google Scholar 

Schwarz F, Aebi M. Mechanisms and principles of N-linked protein glycosylation. Curr Opin Struct Biol. 2011;21:576–82.

Article  CAS  PubMed  Google Scholar 

Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie. 2001;83:727–37.

Article  CAS  PubMed  Google Scholar 

Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem. 2008;143:725–9.

Article  CAS  PubMed  Google Scholar 

Li J, Hsu HC, Mountz JD, Allen JG. Unmasking fucosylation: from cell adhesion to immune system regulation and diseases. Cell Chem Biol. 2018;25:499–512.

Article  PubMed  Google Scholar 

Shan M, Yang D, Dou H, Zhang L. Fucosylation in cancer biology and its clinical applications. Prog Mol Biol Transl Sci. 2019;162:93–119.

Article  CAS  PubMed  Google Scholar 

Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol. 2009;50:592–603.

Article  CAS  PubMed  Google Scholar 

Nguyen AT, Chia J, Ros M, Hui KM, Saltel F, Bard F. Organelle specific O-glycosylation drives MMP14 activation, tumor growth, and metastasis. Cancer Cell. 2017;32:639–53.

Article  CAS  PubMed  Google Scholar 

Wu Q, Liu HO, Liu YD, Liu WS, Pan D, Zhang WJ, et al. Decreased expression of hepatocyte nuclear factor 4alpha (Hnf4alpha)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity. J Biol Chem. 2015;290:1170–85.

Article  CAS  PubMed  Google Scholar 

Wu YM, Liu CH, Hu RH, Huang MJ, Lee JJ, Chen CH, et al. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Cancer Res. 2011;71:7270–9.

Article  CAS  PubMed  Google Scholar 

Liu Y, Liu H, Yang L, Wu Q, Liu W, Fu Q, et al. Loss of N-Acetylgalactosaminyltransferase-4 orchestrates oncogenic MicroRNA-9 in hepatocellular carcinoma. J Biol Chem. 2017;292:3186–3200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang MJ, Hu RH, Chou CH, Hsu CL, Liu YW, Huang J, et al. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling. Oncotarget. 2015;6:5650–65.

Article  PubMed  PubMed Central  Google Scholar 

Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, et al. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Cancer Res. 2013;73:5580–90.

Article  CAS  PubMed  Google Scholar 

Liu CH, Hu RH, Huang MJ, Lai IR, Chen CH, Lai HS, et al. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin beta1 glycosylation and activity. PLoS One. 2014;9:e94995.

Article  PubMed  PubMed Central  Google Scholar 

Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L, et al. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol. 2012;29:985–93.

Article  CAS  PubMed  Google Scholar 

Yang Y, Yan Y, Yin J, Tang N, Wang K, Huang L, et al. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner. Signal Transduct Target Ther. 2023;8:63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu Y, Jiang M, Wu N, Xu B, Li W, Liu H, et al. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 2020;10:9830–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou P, Chang WY, Gong DA, Huang LY, Liu R, Liu Y, et al. O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. Oncogene. 2023;42:725–736.

Article  CAS  PubMed  Google Scholar 

Jiang T, Yang J, Yang H, Chen W, Ji K, Xu Y, et al. SLC35B4 stabilizes c-MYC protein by O-GlcNAcylation in HCC. Front Pharm. 2022;13:851089.

Article  CAS  Google Scholar 

Wu W, Zheng X, Wang J, Yang T, Dai W, Song S, et al. O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma. Cell Death Dis. 2018;9:970.

Article  PubMed  PubMed Central  Google Scholar 

Cao B, Duan M, Xing Y, Liu C, Yang F, Li Y, et al. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E. J Cell Mol Med. 2019;23:2384–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buren S, Gomes AL, Teijeiro A, Fawal MA, Yilmaz M, Tummala KS, et al. Regulation of OGT by URI in response to glucose confers c-MYC-dependent survival mechanisms. Cancer Cell. 2016;30:290–307.

Article  CAS  PubMed  Google Scholar 

Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu X, et al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat Commun. 2017;8:15280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao S, Miao Y, Liu Y, Liu X, Fan X, Lin Y, et al. Reciprocal regulation between O-GlcNAcylation and beta-Catenin facilitates cell viability and inhibits apoptosis in liver cancer. DNA Cell Biol. 2019;38:286–96.

Article  CAS  PubMed  Google Scholar 

Takayama H, Ohta M, Iwashita Y, Uchida H, Shitomi Y, Yada K, et al. Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study. BMC Cancer. 2020;20:192.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif